Low-dose statin treatment increases prostate cancer aggressiveness

Prostate cancer is diagnosed late in life, when co-morbidities are frequent. Among them, hypertension, hypercholesterolemia, diabetes or metabolic syndrome exhibit an elevated incidence. In turn, prostate cancer patients frequently undergo chronic pharmacological treatments that could alter disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Caro-Maldonado, Alfredo, Camacho, Laura, Zabala-Letona, Amaia, Torrano, Verónica, Fernández-Ruiz, Sonia, Zamacola-Bascaran, Kepa, Arreal, Leire, Valcárcel-Jiménez, Lorea, Martín-Martín, Natalia, Flores, Juana M., Cortazar, Ana R., Zúñiga-García, Patricia, Arruabarrena-Aristorena, Amaia, Guillaumond, Fabienne, Cabrera, Diana, Falcón-Perez, Juan M., Aransay, Ana M., Gomez-Muñoz, Antonio, Olivan, Mireia, Morote, Juan, Carracedo, Arkaitz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788577/
https://www.ncbi.nlm.nih.gov/pubmed/29416709
http://dx.doi.org/10.18632/oncotarget.22217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788577/
https://www.ncbi.nlm.nih.gov/pubmed/29416709
http://dx.doi.org/10.18632/oncotarget.22217

Ejemplares similares